Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label randomized trial of lopinavir/ritonavir monotherapy versus boosted protease inhibitor triple therapy in HIV-1 patients
2009-014430-25Phase 4Completed
- Sponsor
- Sociedad Andaluza de Enfermedades Infecciosas
- Start
- Oct 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lopinavir and ritonavir in Human immunodeficiency virus infection type 1 (2 arms), sponsored by Sociedad Andaluza de Enfermedades Infecciosas. Primary endpoint: Quality of life. Started Oct 2009; status: completed.
02
Drugs
lopinavirritonavir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2009-014430-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014430-25.